Pharma groups: FDA is exceeding its authority in risk management plan guidance
Regulatory NewsJoanne S. Eglovitch
ComplianceMedical DevicesNorth AmericaPharmaceuticalsQuality Assurance and ControlSupply Chain ManagementRegulatory NewsJoanne S. EglovitchComplianceMedical DevicesNorth AmericaPharmaceuticalsQuality Assurance and ControlSupply Chain Management